Stock Price Prediction

MERC stock currently trades near $6.31, with a recent analyst price target of $7, reflecting a modest 10.9% upside. The bull's view hinges on its exposure to the growing demand for weight-loss drug coverage, as highlighted in recent Mercer surveys, which could drive revenue growth. However, the stock's "Hold" rating suggests limited near-term catalysts for significant price appreciation.

MERC stock closed at $6.73 on January 31, 2025, down 1.90% for the day. The bearish view stems from its weak technical indicators, with the price below the Fibonacci pivot of $6.59 and RSI at 56.29, suggesting limited momentum. Additionally, RBC Capital's "Hold" rating with a $7 target implies only a modest 10.94% upside, reflecting cautious sentiment.

The market consensus for MERC's revenue in the upcoming quarter is projected to be approximately $493M USD.

The market consensus for MERC's eps in the upcoming quarter is projected to be approximately $0.05 USD.